Capricor Therapeutics, Inc. (CAPR) Discusses HOPE-3 Phase III Top Line Data for Deramiocel in Duchenne Muscular Dystrophy Transcript
Capricor Therapeutics(US:CAPR) Seeking Alpha·2025-12-06 14:18PresentationOperator Good morning, ladies and gentlemen, and welcome to the Capricor Therapeutics HOPE-3 Phase III Topline Data Call. [Operator Instructions] As a reminder, this conference call is being recorded. I would now like to turn the conference over to our host, Mr. AJ Bergmann, Capricor's Chief Financial Officer. Please go ahead. ...